U.K. cancer care technology developer Endomag has opened new headquarters in Cambridge, U.K.
The company has also opened a U.S. office in Austin, TX, Endomag said. In January, it started a U.S. trial of its Sentimag and Sienna+ magnetic detection system, designed to stage breast cancer during sentinel lymph node biopsy procedures. The device has successfully treated more than 6,000 breast cancer patients in 20 countries, according to the firm.
